Stonepine Capital Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-167,580
Closed -$414K 82
2025
Q1
$414K Buy
167,580
+34,710
+26% +$82.5K 0.4% 40
2024
Q4
$417K Buy
+132,870
New +$643K 0.34% 41

Other funds holding SLRN

Stonepine Capital Management's SLRN Position: Q2 2025 in Review

Stonepine Capital Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 167,580 shares — an estimated $414K sold.

Stonepine Capital Management first reported a position in SLRN in Q4 2024 and held it in 2 quarters. The position peaked at $417K in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Stonepine Capital Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 167,580 ACELYRIN shares in Q2 2025, an estimated $414K.
  • Stonepine Capital Management first reported a position in ACELYRIN in Q4 2024 and held it in 2 quarters.
  • Stonepine Capital Management's ACELYRIN position peaked at $417K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.